2. The drug was removed from the Internet, because it failed to pass the consistency evaluation and had been evaluated by 3 companies
-
Last Update: 2019-03-20
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On March 20, Jiangxi Medical purchasing service center issued the notice of Jiangxi Province on adjusting the purchasing qualification of some products in 2019 Among them, 2 drugs failed to pass the conformity evaluation, and 3 other enterprises have passed the conformity evaluation, and the online purchasing qualification was suspended, including atorvastatin calcium produced by Sandoz and Lipei of Tianjin Pharmaceutical Research Institute Pharmaceutical Co., Ltd Ketone tablets In addition, the purchase qualification of rosuvastatin calcium tablets of Nanjing Xiansheng Dongyuan Pharmaceutical Co., Ltd was restored due to the consistency evaluation Details are as follows: adjustment of online purchasing qualification of some drugs
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
